Create an Account - Increase your productivity, customize your experience, and engage in information you care about.
LANSING, MICH. Michigan Department of Health and Human Services (MDHHS) officials today provided additional information about COVID-19 vaccination plans for Michigan, including priority groups for vaccination administration, the vaccine development and safety process and where Michiganders can find more details.
Yesterday, a U.S. Food and Drug Administration advisory panel recommended approval for one of the vaccines that could be ready for distribution as early as next week. Gov. Gretchen Whitmer also signed Executive Order 2020-193, creating the bipartisan Protect Michigan Commission to help educate Michiganders about an approved vaccine. Michigan health officials have set a goal of vaccinating 70% of Michiganders 18 years of age or older, about 5.4 million adults, by the end of 2021.
“The COVID-19 vaccine will help all our communities eliminate the virus,” said Dr. Joneigh Khaldun, MDHHS chief medical executive and chief deputy for health. “Because initial allocations of vaccine will be limited, we must prioritize how the vaccine will be distributed across the state and will use the guidance and principles outlined by the CDC and national experts. We want every adult to be planning now for how they will get their vaccine once it becomes available to them.”
MDHHS is following the Centers for Disease Control and Prevention recommendations for prioritization of distribution and administration of COVID-19 vaccines. CDC recommendations are based on input from the Advisory Committee on Immunization Practices (ACIP). ACIP is a federal advisory committee made up of medical and public health experts who develop recommendations on the use of vaccines in the United States. MDHHS has also obtained input from a stakeholder group of Michigan public health and health care leaders and reviewed correspondence from the public.
Distribution of the vaccine will be in a phased approach, with an emphasis on both ensuring thecontinuing functioning of the health care system and essential services in the community and protectingpeople at increased risk for severe COVID-19 illness. These prioritizations may change as moreinformation on vaccine effectiveness and additional vaccination products become available.
Phases are as follows:
MDHHS has provided additional prioritization guidance within these categories. It is important to notethat vaccination in one phase may not be complete before vaccination in another phase begins.Vaccination in these phases will likely overlap. The timing of the start of vaccination in a phase isdependent on guidance from CDC and ACIP, the supply of vaccine from the manufacturer, how vaccineis allocated from the federal level to Michigan and the capacity to administer the vaccine to populations.
Vaccine distribution will roll out over a series of weeks, and current estimates are that by late Spring 2021enough vaccine will be available for everyone who is recommended to receive it. A variety of partners willbe engaged in the distribution and administration process, including hospitals, pharmacies, local healthdepartments, EMS providers and outpatient clinics. The Michigan National Guard is also supportingvaccination efforts in some settings.
There will be no out-of-pocket costs to individuals for the vaccine, however, healthcare providers may billinsurance for administrative costs. The COVID-19 vaccine will require two doses, separated by three orfour weeks depending on the manufacturer. Michiganders should receive both doses in order to have fullprotection from the virus. Individuals who receive the vaccine may experience mild side effects such aslow-grade fever, sore arm and fatigue, which indicate that the vaccine is working. There is a robust stateand national process for tracking vaccines and reporting side effects.
MDHHS stresses Michiganders should continue to wear masks, social distance from those not in theirhousehold and wash their hands often, even after receiving the vaccine.
Khaldun said it is important to note that while scientists worldwide are working to develop a COVID-19vaccine faster than any vaccine before, they are still following the proven process. Scientists had alreadybegun research for coronavirus vaccines during previous outbreaks caused by related coronavirusessuch as SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome).That earlier research provided a head start for rapid development of vaccines to protect against infectionwith COVID-19.
“The process for approval of a COVID-19 vaccine is scientifically sound, and no steps have beenskipped,” Khaldun said. “People should know what to expect when they get a vaccine- such as mild sideeffects like a sore arm or low-grade fever. They should also plan on making sure they get their seconddose to make sure they get the full benefit of the vaccine.”
Michigan residents seeking more information about the COVID-19 vaccine can visitMichigan.gov/COVIDvaccine. As additional information and resources become available, it will be postedto this site.
Information around this outbreak is changing rapidly. The latest information is available atMichigan.gov/Coronavirus and CDC.gov/Coronavirus.